Transitional Cell Carcinoma — Trials

Transitional Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

734 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 253
Recruiting: 125
Ph III recruiting: 17
Growth YoY: +47.5%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (119)

clinicaltrialsPublishedShowing 301–306 of 306 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05600127	Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer(CHASIT)	recruiting	Phase 2	64	Erasmus Medical CenterOTHER	1	Sep 8, 2023	clinicaltrials
NCT06026189	Safely Reduce Cystoscopic Evaluations for Hematuria Patients(SeARCH)	recruiting	N/A	1,100	Erasmus Medical CenterOTHER	1	Sep 6, 2023	clinicaltrials